186 related articles for article (PubMed ID: 19901913)
41. Micro-RNA expression in the urinary sediment of patients with chronic kidney diseases.
Szeto CC; Ching-Ha KB; Ka-Bik L; Mac-Moune LF; Cheung-Lung CP; Gang W; Kai-Ming C; Kam-Tao LP
Dis Markers; 2012; 33(3):137-44. PubMed ID: 22960330
[TBL] [Abstract][Full Text] [Related]
42. Chromosomal telomere shortening of kidney cells in IgA nephropathy by the measurement of DNA in urinary sediment.
Szeto CC; Poon PY; Lai FM; Chow KM; Szeto CY; Li PK
Clin Nephrol; 2005 Nov; 64(5):337-42. PubMed ID: 16312260
[TBL] [Abstract][Full Text] [Related]
43. Clinicopathological correlation of intrarenal cytokines and chemokines in IgA nephropathy.
Lim CS; Yoon HJ; Kim YS; Ahn C; Han JS; Kim S; Lee JS; Lee HS; Chae DW
Nephrology (Carlton); 2003 Feb; 8(1):21-7. PubMed ID: 15012746
[TBL] [Abstract][Full Text] [Related]
44. Predictors of Progression in IgA Nephropathy in Childhood.
Mizerska-Wasiak M; Małdyk J; Turczyn A; Cichoń-Kawa K; Rybi-Szumińska A; Wasilewska A; Bieniaś B; Zajączkowska M; Miklaszewska M; Pietrzyk J; Demkow U; Roszkowska-Blaim M; Pańczyk-Tomaszewska M
Adv Exp Med Biol; 2017; 955():65-73. PubMed ID: 27718216
[TBL] [Abstract][Full Text] [Related]
45. Increased Serum IgA in Children with IgA Nephropathy, Severity of Kidney Biopsy Findings and Long-Term Outcomes.
Mizerska-Wasiak M; Małdyk J; Pańczyk-Tomaszewska M; Turczyn A; Cichoń-Kawa K; Rybi-Szumińska A; Wasilewska A; Firszt-Adamczyk A; Stankiewicz R; Bieniaś B; Zajączkowska M; Gadomska-Prokop K; Grenda R; Miklaszewska M; Pietrzyk J; Pukajło-Marczyk ; Zwolińska D; Szczepańska M; Demkow U; Roszkowska-Blaim M
Adv Exp Med Biol; 2015; 873():79-86. PubMed ID: 26269025
[TBL] [Abstract][Full Text] [Related]
46. Genome-wide microRNA expression profiling in renal cell carcinoma: significant down-regulation of miR-141 and miR-200c.
Nakada C; Matsuura K; Tsukamoto Y; Tanigawa M; Yoshimoto T; Narimatsu T; Nguyen LT; Hijiya N; Uchida T; Sato F; Mimata H; Seto M; Moriyama M
J Pathol; 2008 Dec; 216(4):418-27. PubMed ID: 18925646
[TBL] [Abstract][Full Text] [Related]
47. Detection of microRNA Expression in the Kidneys of Immunoglobulin a Nephropathic Mice.
Kaneko S; Yanai K; Ishii H; Aomatsu A; Ito K; Hirai K; Ookawara S; Ishibashi K; Morishita Y
J Vis Exp; 2020 Jul; (161):. PubMed ID: 32716396
[TBL] [Abstract][Full Text] [Related]
48. Value of urinary levels of interleukin-6, epidermal growth factor, monocyte chemoattractant protein type1 and transforming growth factor β1 in predicting the extent of fibrosis lesions in kidney biopsies of patients with IgA nephropathy.
Segarra-Medrano A; Carnicer-Caceres C; Valtierra-Carmeno N; Agraz-Pamplona I; Ramos-Terrades N; Jatem Escalante E; Ostos-Roldan E
Nefrologia; 2017; 37(5):531-538. PubMed ID: 28946966
[TBL] [Abstract][Full Text] [Related]
49. Glomerular solidification is associated with nephritis-related clinical parameters in IgA nephropathy.
Inoue T; Luo Y; Seto T; Suzuki H; Okada H
Ren Fail; 2019 Nov; 41(1):893-898. PubMed ID: 31557071
[No Abstract] [Full Text] [Related]
50. Abnormal miR-148b expression promotes aberrant glycosylation of IgA1 in IgA nephropathy.
Serino G; Sallustio F; Cox SN; Pesce F; Schena FP
J Am Soc Nephrol; 2012 May; 23(5):814-24. PubMed ID: 22362909
[TBL] [Abstract][Full Text] [Related]
51. Circulating MiR-29a, Possible Use as a Biomarker for Monitoring IgA Nephropathy.
Hu H; Wan Q; Li T; Qi D; Dong X; Xu Y; Chen H; Liu H; Huang H; Wei C; Zhou W; Jiang S; Mo Z; Liao F; Xu Q; He Y
Iran J Kidney Dis; 2020 Mar; 14(2):107-118. PubMed ID: 32165595
[TBL] [Abstract][Full Text] [Related]
52. Prognostic factors and therapy assessment of IgA nephropathy: report from a single unit in iran.
Soleymanian T; Najafi I; Salimi BH; Broomand B
Ren Fail; 2011; 33(6):572-7. PubMed ID: 21663387
[TBL] [Abstract][Full Text] [Related]
53. Outcome of IgA nephropathy in adults graded by chronic histological lesions.
To KF; Choi PC; Szeto CC; Li PK; Tang NL; Leung CB; Wang AY; Ho KK; Wong TY; Lui SF; Lai FM
Am J Kidney Dis; 2000 Mar; 35(3):392-400. PubMed ID: 10692264
[TBL] [Abstract][Full Text] [Related]
54. MicroRNAs in kidney physiology and disease.
Trionfini P; Benigni A; Remuzzi G
Nat Rev Nephrol; 2015 Jan; 11(1):23-33. PubMed ID: 25385286
[TBL] [Abstract][Full Text] [Related]
55. Association of glomerular DNA damage and DNA methylation with one-year eGFR decline in IgA nephropathy.
Hayashi K; Hishikawa A; Hashiguchi A; Azegami T; Yoshimoto N; Nakamichi R; Tokuyama H; Itoh H
Sci Rep; 2020 Jan; 10(1):237. PubMed ID: 31937846
[TBL] [Abstract][Full Text] [Related]
56. Plasma microRNA signature of patients with IgA nephropathy.
Wu J; Zhang H; Wang W; Zhu M; Qi LW; Wang T; Cheng W; Zhu J; Shan X; Huang Z; Zhang L; Chen Y; Sun B; Zhao X; Qian J; Zhu W; Zhou X; Xing C
Gene; 2018 Apr; 649():80-86. PubMed ID: 29459010
[TBL] [Abstract][Full Text] [Related]
57. Correlation between glomerular morphology and renal haemodynamic response to amino-acid administration in patients with IgA nephropathy.
Pluvio C; de Pascale E; Giordano M; Cirillo D; Carone M; Pluvio M; Castellino P; Giordano C
Nephrol Dial Transplant; 1996 Dec; 11(12):2421-5. PubMed ID: 9017616
[TBL] [Abstract][Full Text] [Related]
58. Elevated hsa-miR-590-3p expression down-regulates HMGB2 expression and contributes to the severity of IgA nephropathy.
Zhai Y; Qi Y; Long X; Dou Y; Liu D; Cheng G; Xiao J; Liu Z; Zhao Z
J Cell Mol Med; 2019 Nov; 23(11):7299-7309. PubMed ID: 31557418
[TBL] [Abstract][Full Text] [Related]
59. Intrarenal Arterial Lesions Are Associated with Higher Blood Pressure, Reduced Renal Function and Poorer Renal Outcomes in Patients with IgA Nephropathy.
Zhang Y; Sun L; Zhou S; Xu Q; Xu Q; Liu D; Liu L; Hu R; Quan S; Xing G
Kidney Blood Press Res; 2018; 43(2):639-650. PubMed ID: 29698975
[TBL] [Abstract][Full Text] [Related]
60. Soluble interleukin-2 receptor alfa predicts renal outcome in IgA nephropathy.
Lundberg S; Lundahl J; Gunnarsson I; Sundelin B; Jacobson SH
Nephrol Dial Transplant; 2012 May; 27(5):1916-23. PubMed ID: 21940483
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
